Dynavax Technologies
Utility Patents

Last updated:

List of all Dynavax Technologies patents 7 in total

Status Patent
Grant
Utility: Toll-like receptor antagonist compounds and methods of use External link
Filling date: 8 Sep 2025 Issue date: 28 Jun 2022
Grant
Utility: Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 14 Apr 2020
Grant
Utility: Branched chimeric compounds, and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Administration of polynucleotide toll-like receptor 9 agonists for treating cancer External link
Filling date: 8 Sep 2025 Issue date: 6 Aug 2019

Showing 1 to 7 of 7 patents.